New real-world research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) reveals that people living with multiple sclerosis (MS) face a much higher risk of being hospitalised and dying from COVID-19 than the general population.
Pharma companies delist patents from FDA’s Orange Book following FTC challenges
At least three pharma companies have requested to pull patents from an FDA database after the Federal Trade Commission challenged more than 100 patents it